Cheng Huan, Wu Xinyu, Li Jingru, Wang Luqiao
Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, People's Republic of China.
Department of Cardiology, Zhumadian City Central Hospital, Zhumadian, Henan, 463000, People's Republic of China.
Int J Gen Med. 2025 Jun 12;18:3129-3150. doi: 10.2147/IJGM.S524189. eCollection 2025.
Coronary artery disease (CAD), is a global cardiovascular disease that is characterized by myocardial ischemia and hypoxia caused by coronary artery occlusion. Circular RNAs (CircRNAs) is a particular kind of endogenous non-coding RNA, which can affect the occurrence and development of CAD. Concurrently, several circRNAs display stable persistence in CAD patients, attributable to their exceptional exonuclease resistance, thereby harboring the capacity to evolve into a biomarker for CAD diagnosis and prognosis. This article endeavors to clarify the pivotal role of circRNAs in the intricate pathophysiological processes underlying CAD patients or CAD disease models based on their unique biological characteristics and functionalities, and further discuss their prospects in clinical applications of CAD.
冠状动脉疾病(CAD)是一种全球性心血管疾病,其特征是冠状动脉阻塞导致心肌缺血和缺氧。环状RNA(CircRNAs)是一种特殊的内源性非编码RNA,可影响CAD的发生和发展。同时,几种环状RNA在CAD患者中表现出稳定的持续性,这归因于它们对核酸外切酶的特殊抗性,因此有能力发展成为CAD诊断和预后的生物标志物。本文旨在基于其独特的生物学特性和功能,阐明环状RNA在CAD患者或CAD疾病模型复杂病理生理过程中的关键作用,并进一步探讨其在CAD临床应用中的前景。